Use of 2 -anilino - 3 , 4 -dihydro - quinazolines as 5HT5A receptor antagonists

Details for Australian Patent Application No. 2006224636 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Peters, Jens-uwe; Steward, Lucinda; Kolczewski, Sabine; Luebbers, Thomas; Gobbi, Luca Claudio; Alanine, Alexander

Agent Spruson & Ferguson

Pub. Number AU-A-2006224636

PCT Pub. Number WO2006/097391

Priority 05102001.4 15.03.05 EP

Filing date 8 February 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097391 Priority application(s): WO2006/097391

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224653-Method and system for determining position and orientation of an object

2006224634-Method for producing blends consisting of polystyrene and of a cross-linked polyvinyl pyrrolidone having a reduced styrene residual monomer content